The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
Subscribe To Our Newsletter & Stay Updated
